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Abstract 
Objective: To explore the impact of risk-adjustment on surgical complication rates 
(CRs) for benchmarking gynaecological-oncology centres.  
Design: Prospective cohort study  
Setting: Ten UK accredited gynaecological-oncology centres 
Population: Women undergoing major surgery on a gynaecological-oncology 
operating list 
Methods: Patient co-morbidity, surgical procedures and intraoperative (IntraOp) 
complications were recorded contemporaneously by surgeons for 2948 major surgical 
procedures. Postoperative (PostOp) complications were collected from hospitals and 
patients. Risk-prediction models for IntraOp and PostOp complications were created 
using penalised (lasso) logistic regression using over 30 potential patient/surgical risk-
factors.  
Main outcome measures: Observed and risk-adjusted IntraOp and PostOp CRs for 
individual hospitals were calculated. Benchmarking using colour-coded funnel plots 
and observed-to-expected ratios was undertaken. 
Results: Overall, IntraOp CR was 4.7%(95%CI 4.0-5.6) and PostOp CR 
25.7%(95%CI 23.7-28.2). The observed CRs for all hospitals were under the upper 
95% control limit for both IntraOp and PostOp funnel plots. Risk-adjustment and use 
of observed-to-expected ratio resulted in one hospital moving to the >95-98%CI(red) 
band for IntraOp CRs. Use of only hospital-reported data for PostOp CRs would have 
resulted in one hospital being unfairly allocated to the red band. There was little 
concordance between IntraOp and PostOp CRs.  
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Conclusions: The funnel plots and overall IntraOp(≈5%) and PostOp(≈26%) CRs 
could be used for benchmarking gynaecological-oncology centres. Hospital 
benchmarking using risk-adjusted CRs allows fairer institutional comparison.  IntraOp 
and PostOp CRs are best assessed separately. As hospital under-reporting is 
common for post-operative complications, use of patient-reported outcomes is 
important. 
 
Keywords: UKGOSOC, complications, gynaecological oncology, risk adjustment, 
centres, benchmarking, comparison, surgery 
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UK gynaecological oncology centres allows fairer comparison 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
5 
 
Introduction 
There is a drive within the National Health Service (NHS) to increase transparency 
and improve quality and safety. To this end, one of the initiatives in surgery has been 
to publish outcomes data for hospitals and more recently for individual surgeons which 
have been sourced from national clinical audits in some specialties and in most from 
administrative data. (1, 2) 
While surgical data on a national level has been collected in  specialities such as 
cardiothoracic (3) and orthopaedic (4) surgery and  certain cancers such as lung (5), 
colorectal (6) and head and neck (7), there is paucity of such data in gynaecological 
oncology (GO). To address this, the United Kingdom Gynaecological Oncology 
Surgical Outcomes and Complications (UKGOSOC) (8) study was undertaken to 
prospectively capture data on surgery with a view to setting benchmarking standards. 
In this cohort, the overall intraoperative (IntraOp) complication rate (CR) was 4.7% (8) 
and the postoperative (PostOp) CR was 25.7%. (9) However use of observed 
complication rates (CRs) for centre level comparisons does not take into account 
patient comorbidity, underlying disease or surgical complexity, all of which can impact 
on the risk of a complication. (8) The use of unadjusted crude CRs has resulted in 
significant unease amongst surgeons and hospitals due to the variations in prevalence 
of surgical risk factors. Concerns have been raised that it might deter surgery being 
undertaken in ‘high-risk’ patients with significant comorbidity. We report on the impact 
of risk-adjustment of surgical CRs on benchmarking of GO at hospitals participating in 
UKGOSOC. 
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Methods 
Study Design 
The UKGOSOC study design has been previously described. (8, 9) In brief, ten UK GO 
centres collected data using web-based software on consented women undergoing 
major gynaecological cancer surgery. Surgeons entered patient co-morbidity, surgical 
procedures and IntraOp complications (Table S1) contemporaneously in theatre. 
PostOp complications (Table S2) were defined as occurring up to eight weeks after 
surgery. These were entered on to the online database during the admission by the 
hospital team. Following discharge from hospital, patient-reported complications data 
was also collected using postal follow-up. (9) 
Statistical Methods 
All reported major surgery was used to calculate IntraOp CR. All reported PostOp 
complications were graded (I-V) according to severity using the Clavien and Dindo 
system.(10) Grade 1 complications were excluded from analysis. A PostOp 
complication for this analysis was defined as one of Grade II-V severity. Only those 
surgeries where both hospital and patient follow-up data were available, were included 
in the primary analysis, with PostOp complications including those reported by the 
clinical team (hospital-reported), the patient (patient-reported) or both. A secondary 
analysis based on the whole dataset and only hospital-reported PostOp complications, 
was also undertaken. The outcome was treated as strictly binary and a surgery was 
coded as having a complication irrespective of the number of complications.(8) The 
recorded risk factors for IntraOp and PostOp complications have been described 
previously (8) and are listed in Tables 1 and 3. Separate comparisons were undertaken 
for IntraOp and PostOp CRs.  All methods described below apply to both. 
Data description 
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Outcome and categorical risk factors were cross tabulated by hospitals. To assist 
identification of imbalance in risk factors across hospitals, chi-squared tests were 
performed. Associated p-values were not used as a formal test measure for the factors 
with small category counts (<5) at any hospital. Continuous risk factors were 
summarised by within-hospital means and standard deviations, and F test statistics 
and p-values from an analysis of variance were similarly used to aid assessment of 
hospital variation.  
 
Risk prediction and penalised regression 
Logistic regression models were used for risk prediction, though parameter estimates 
were based on a penalised method (least absolute shrinkage and selection operator 
or ‘lasso’) (11) rather than maximum likelihood (ML). A fundamental issue involved in 
prognostic model construction is that of ‘events per variable’ (EPV) (12), where the 
number of ‘events’ in a binary regression model is taken as the total of the less 
common outcome. A fitted model should have an EPV of at least 10 (13, 14), where the 
variable count includes all levels of a categorical variable. The EPV requirement holds 
even if variable selection (stepwise methods) is performed, so that the variable count 
is based on the full model. A limited number of EPV can cause validation problems 
when using ML for parameter estimates, as the model becomes over-fitted and 
prediction error is inflated. As a result many prediction models fail to be successfully 
validated (12).  
 The lasso deliberately biases (shrinks) the regression estimates toward zero, 
reducing the mean square prediction error (MSPE) which is a function of the variability, 
as well as the bias, of the predictions. As a result, despite intentional bias, penalised 
methods typically provide better prediction than ML. A brief description of the lasso 
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method is presented in Appendix 1. Formal inference for biased estimates is dubious 
so p-values should be used only for approximate guidance. (11) The user-written Stata 
commands plogit and plsearch were used to fit lasso-shrunk logistic models. 
Equivalent models fitted by ML are presented for comparison. 
Model fit was assessed using the Hosmer-Lemeshow test and model specification with 
the link test. A receiver operating characteristic (ROC) curve using the predicted 
probabilities generated by leave-one-out cross-validation (LOO-CV) was calculated 
and overall performance (discrimination) assessed by the area under the curve (AUC). 
By regressing the outcome on bootstrapped linear predictions (log odds) for each 
subject, the calibration slope (CS) (12, 13) could be estimated as the mean slope of 1000 
bootstrap samples, where a slope close to one suggests good calibration and (much) 
less than one implies over-fitting of the model. An over-fitted model will give predictions 
that are too narrow in range. 
 
Hospital rate adjustments 
Observed IntraOp and PostOp CRs for hospitals were compared using funnel plots, a 
standard approach to institutional comparison. (15, 16) They were generated by plotting 
each hospital’s observed CR against sample size and assessed with respect to 
confidence bands that signify unusually high or low CRs. Control limits for the funnel 
plots were generated using smoothed exact confidence intervals for the overall CR. 
These were displayed using coloured ‘warning’ bands of increasing ‘concern’ with 
regard to increasing CRs : green (up to 80%), yellow (>80%-90%), orange (>90%-
95%), and red (>95-98%)..  
We used the prediction model to produce expected IntraOp and PostOp CRs for each 
hospital and hence an observed-to-expected CR ratio. Bootstrapped confidence 
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intervals for the CR ratio were generated (see Appendix 2) with the same warning 
levels as for the funnel plots, and if the confidence band contained 1, the hospital was 
denoted with the appropriate coloured warning.  
Results 
Intra-operative complications 
2948 surgeries undertaken across 10 hospitals were included in the analysis. 139 had 
at least one IntraOp complication. Although the observed IntraOp CR ranged from 
2.0% to 8.0%, the variation was not significant between hospitals (p=0.052). 
Modelling and fit 
The distribution of risk factors and CRs across the 10 hospitals is detailed in Table S3. 
There was variation across hospitals for most predictors, but particularly for 
laparoscopic approach, grade of surgeon, surgical complexity, final diagnosis and 
American Society for Anaesthesiologists (ASA) grade. 
Of the 2948 surgeries, missing data meant that only 2709 surgeries with 132 
complications could be included when fitting the full model. This resulted in an EPV of 
4.1 given the 32 variables.  The optimised lasso model resulted in four of the 32 
variables being excluded. (Table1) Lasso-shrunk odds ratios are presented in Table 
1, alongside the ML estimates for comparison. The strongest predictors (p <0.05 when 
estimated by ML) of IntraOp complication were surgical complexity (increased risk with 
increasing complexity), previous abdominal surgery (increased risk), diabetes 
(increased risk), metabolic-endocrine disorders other than diabetes (decreased risk) 
and final diagnosis (all cancer types associated with reduced risk relative to ovarian 
cancer). 
The ROC curve based on LOO-CV produced an AUClasso=0.663 (95%CI: 0.616-
0.710), similar to AUCML=0.659 (95% CI: 0.611-0.706), although ROC curves are 
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affected only by rank order and not magnitude. The mean CSlasso of 0.871 suggested 
a slight narrowness of predictions, although the 2.5th-97.5th centile of the slopes 
(0.717-1.068) contain the optimal value of 1. In contrast, the CSML=0.712 (95%CI: 
0.364-0.887) indicated that the prediction range was limited, and hence the model 
over-fitted, without parameter shrinkage. 
 
Hospital rate adjustments 
Figure 1a shows the funnel plot allowing a simple comparison of observed IntraOp CR 
by hospital. A majority of the hospitals are within the green band with some, such as 
Hospital F, having a significantly low IntraOp CR outside the 95% (≈2 standard 
deviations) control limits. Hospitals J and E have CR higher than the overall IntraOp 
CR but the moderate number of surgeries analysed from these hospitals (150 and 
181, respectively) means a reduced confidence in their outlier status and they lie within 
the yellow band (control limits >80%-90%). Figure 1b shows the observed-to-expected 
CR ratio, adjusted for risk factor prevalence in the 10 hospitals. The spread of 
expected IntraOp CR for hospitals is between 3.9% and 5.4% (Table 2a). In Figure 1b 
Hospital F is confirmed as having a low IntraOp CR after adjustment. The 95% 
confidence interval for Hospital E is completely above 1, the line of equality 
(observed=expected), and it is coded red (confidence interval >95-98%) marking it as 
a centre with high IntraOp CR. The ratio for Hospital G is also high at 1.8, but with 
wide confidence intervals, hence it remains coded green. Hospital J, which had the 
highest observed IntraOp CR, only has the 3rd highest ratio (Table 2a) and remains 
coded yellow, indicating that its high CR is partially mitigated by a relatively high-risk 
case-mix of surgeries.  
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Post-operative complications 
The primary PostOp CR analysis was restricted to the subset of 1462 surgeries with 
both hospital and patient reported outcomes. 376 had at least one PostOp 
complication. Individual hospital statistics are presented in Table S4. Estimated blood 
loss (EBL) and duration of surgery varied significantly by hospital. The PostOp CR 
varied from 15.6% to 36.2% between hospitals but the difference was not significant 
(p=0.096). The findings were similar for the full dataset (Table S3). 
 
Modelling and fit 
Of the 1462 surgeries missing data meant only 1371 surgeries with 346 events were 
included when fitting the full model. This resulted in an EPV of 9.9 given the 35 
variables. The optimised lasso model resulted in 15 variables out of 35 being removed 
from the model (Table 3). Only duration of surgery appeared to be a strong predictor 
of PostOp complications, though coagulation-thrombosis, and musculoskeletal 
disorders and diabetes (all increase risk), laparoscopic approach (decreases risk) and 
final diagnosis (cervical and vulval cancer increase risk relative to ovarian cancer) 
were significant at the 5% level using ML. The ROC curve based on LOO-CV produced 
an AUClasso=0.659 (95%CI:0.585-0.733), significantly larger than AUCML=0.569 
(95%CI:0.487-0.652) as tested using the method described by DeLong et al 
(17)(p=0.0003). The mean CSlasso=1.008 (95%CI:0.799-1.264) suggested near-
perfectly calibrated predictions. By comparison, a mean CSML=0.689 (95%CI: 0.562-
0.835) strongly indicated that the ML-based prediction range was too narrow, and 
hence the model was over-fitted. 
 
Hospital rate adjustments 
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Figure 1c compares the observed PostOp CRs of the 10 hospitals using a funnel plot. 
The overall CR was 25.7%. None of the hospitals had a PostOp CR that was 
significantly higher than the overall CR. Hospital J had the highest PostOp CR (36.2%) 
but as this was based on only 58 surgeries, it lies within the yellow (control limits >80%-
90%) band. Hospitals G (15.6%) and I (17.1%) have notably low CR. Figure 1d shows 
the observed-to-expected PostOp CR ratio, with actual values found in Table 2b. The 
spread of expected PostOp CR for hospitals is between 20.1% and 28.5%. None of 
the hospitals have a CR ratio significantly different above 1, the line of equality 
(observed=expected) at the 5% level, though Hospital J remains within the yellow 
band.  
All PostOp CRs are lower if hospital reported statistics alone are used. (Figure S1- 
faded colour-coding) Hospital D is in the red band when hospital reported rates alone 
are used. However, when surgeries with both hospital and patient reported statistics 
are used, hospital D is in the green band suggesting that differences in under-reporting 
can significantly impact on hospital comparisons. (Figure S1 - bright colour-coding) 
 
Generally, there was little concordance between IntraOp and PostOp CR. Hospitals G 
and E which were among the centres with high IntraOp CR, had some of the lowest 
PostOp CRs, both observed and risk-adjusted. (Figure 1) 
 
Discussion 
Main Findings 
Risk-adjustment did not make a significant difference to the CRs for majority of 
centres, but helped to delineate the outliers better. The shaded funnel plots and 
observed versus expected ratios generated made comparisons easy to comprehend. 
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Hospital under-reporting is common for PostOp complications and inclusion of patient-
reported outcomes is important to ensure valid comparison between institutions. Risk 
factors for IntraOp and PostOp CRs were largely different and even after adjustment 
there was no concordance between hospital IntraOp and PostOp CRs. The overall 
IntraOp (≈5%) and PostOp (≈26%) CR derived from this study could be used to 
benchmark performance in GO.  
 
Strength and Limitations 
This is the first large prospective multicentre study in GO to develop risk-adjusted CRs 
for inter-institutional comparison of surgical outcomes. Although such data is available 
in other specialties, (3, 5, 7, 18)  in GO, it is limited  to a retrospective study comparing 
outcomes of ovarian cancer surgery between three US tertiary  centres.(19) 
Whilst the limited number of surgeries entered is not entirely representative of all GO 
operations performed in the UK, this was a huge undertaking for the clinicians 
involved. For the 7 centres we have data for, the inclusion rate of cases ranged from 
64.6% to 97.6% and all cases were prospectively registered prior to surgery.   
We have previously described the risk predictors for IntraOp and PostOp CRs based 
on univariable and multivariable regression.(8) Few of the factors appeared important 
across either model reflecting the difficulty in developing risk-prediction tools. While 
significant effort was required for complete prospective data collection on 2948 
surgeries, given the high EPV rate had significant implications for estimation.  
Use of a data-dependent internal measure (observed overall CR) in lieu of a pre-
specified target rate based on external data and expert opinion was a limitation, and 
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a hospital with a particularly high rate will help push up that value to which all hospitals 
are compared to. Unfortunately there was insufficient published data on GO CRs to 
utilise a prior target rate. Given that there are no apparent institutional outliers in our 
dataset, the observed CRs might be reasonably used as future target rates.  A related 
issue is that the data used to estimate the prediction model was the same to which the 
model was then applied, though cross-validation methods were employed. An external 
dataset is therefore required for proper model validation.  
Interpretation 
Figure 1 suggests the adjustment process may appear to add little value when 
comparing centres, given that most of the predictors appeared to have limited impact 
on outcome. However adjustment helps to better define the level of excess surgical 
complications at a given hospital, and could therefore provide an earlier intimation of 
potential issues. Hospital E was only flagged as having a statistically high IntraOp CR 
(p=0.03) following adjustment. The IntraOp and PostOp CRs did not vary significantly 
between the 10 hospitals, so that for the majority, the observed CRs were within the 
funnel plot control limits. In the broader healthcare community, where the spread of 
quality and CRs is likely to be wider, it is likely that there will be institutions beyond the 
various safety bounds, requiring more precise performance monitoring.   
By contrast, nearly all the predictors varied considerably by hospital, especially those 
involving an element of surgical decision making (laparoscopic approach, surgeon 
grade, surgical complexity). This ‘inter-hospital’ variability in risk factor prevalence is a 
strong argument in itself for the need to adjust for fairer comparison. That risk-
adjustment did not substantively affect results is partially due to parameter shrinkage 
caused by lack of statistical power. Based on our results, a subsequent study 
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modelling IntraOp CRs, would need n≈12000 for hypertension (ORML=1.28; p=0.26) 
to achieve power=80%, for example. With more data some of these factors may 
contribute significantly to CR prediction, both statistically and clinically. The lack of 
association between CR and factors like BMI, especially after open surgery, are 
contrary to previous reports. (20, 21) However, it is evident that much of the outcome 
variability is related to unmeasured (perhaps unobservable) phenomena, and we do 
not expect a surgical complication to be ever predicted with a high degree of 
confidence. 
The difference in ranking order of hospitals for IntraOp and PostOp CRs, for example, 
hospitals G and E, could be due to various reasons including surgical skill, post-
operative care and under-reporting of PostOp complications. Also, since IntraOp and 
PostOp CRs had differing risk factors, we recommend assessing hospitals separately 
for IntraOp and PostOp complications as combining them could mask deficiencies in 
perioperative care at certain hospitals.  
Analysis of only hospital-reported PostOp complications demonstrated that hospital D 
had the highest CR outside the control limits (Figure S1). However, with inclusion of 
patient-reported data hospital D was no longer an outlier, but hospital J’s CR increased 
from close to the 50th to the 90th centile, suggesting hospital D had been more diligent 
at recording all PostOp complications. These findings further substantiate the need for 
including patient-reported PostOp complications to overcome clinician under-
reporting.  
Penalized models may appear complicated but in a limited event situation it is known 
that selection methods may moderate predictors and include noise predictors. (22) 
However, it is straightforward to input predictor values into, say, an Excel sheet pre-
prepared with the necessary formula to calculate risk scores, and calculate confidence 
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limits treating the expected rate as fixed (23) (Table S5). Alternatively, the model 
parameters presented could be used as informative priors for subsequent model 
building by other researchers in a Bayesian context.  
Since morbidity is the main yardstick for benchmarking surgical performance, moving 
forwards, it would be important to have complete and accurate data in a larger 
database. The drawback of clinician-led databases is that all surgical episodes may 
not get recorded due to its heavy reliance on voluntary data entry. (24) Also, some 
centres with high morbidity rates may be hesitant to enter all their data.(25) The 
alternative would be an administrative database like Hospital Episode Statistics (HES) 
where all surgical episodes are automatically recorded, which, might however  have 
incomplete complications data.  Although Nouraei et al (7) found CRs derived from HES 
comparable to the clinician-led head and neck surgery database, this has  not been 
the case with other specialties.(26) A re-audit in one of the participating centres 
demonstrated higher CRs than that derived from HES, but comparable to UKGOSOC. 
(27) Therefore, a reasonable compromise may be to combine HES with a clinician-led 
database. To ensure completeness it would be prudent to minimise the data fields 
requiring clinician entry. It is hoped that mandatory requirement to publish individual 
surgeon’s outcomes will encourage complete and accurate data entry.(1)  Valid case-
mix risk-adjustment is also likely to reassure surgeons and encourage active 
participation in surgical outcomes assessment audits.  
Conclusion 
Risk-adjustment had a modest effect on the rankings of the individual centres based 
on their CRs. However, by accounting for the prevalence of potential risk factors we 
may be able to estimate an adjusted CR that ensures fairer inter-institutional 
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comparison. The overall IntraOp (≈5%) and PostOp (≈26%) CRs and funnel plots 
could be used to benchmark performance of GO centres and even individual surgeons 
with a larger dataset. The risk factors for IntraOp and PostOp complications are 
different and it is important to report on the two CRs separately.  
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Appendix S1: The Lasso method 
 
The lasso (least absolute shrinkage and selection operator) estimator [1] employs a 
penalty term in the likelihood function that is then maximised subject to a constraint on 
the (absolute) sum of the regression coefficients. The penalty term is a function of 
shrinkage parameter (λ) chosen by the investigator, which when equal to zero reduces 
to ML estimation and when tending to infinity results in estimates tending to zero. In 
contrast to the similar ridge regression method, where all the coefficients of the full 
model are partially shrunk, the lasso actually performs a type of variable selection. 
Strong and moderate predictors are shrunk by a certain amount dependent on λ, whilst 
weak predictors may be shrunk to exactly zero and so drop out of the model. The 
choice of λ here was based on a grid search that minimised the generalized cross-
validation error [1]. Note that inference, such as confidence intervals and p-values, 
based on standard errors from the lasso variance-covariance matrix should be treated 
with caution and used only for approximate guidance. Standard errors are not 
particularly meaningful for (deliberately and quite strongly) biased estimates as they 
will exclude the inaccuracy caused by bias [1].  
In contrast to penalized regression methods, model selection procedures are known 
to result in selection- or omission-bias [2], whereby weakly significant variables will be 
infrequently selected, dependent on chance variation, and when selected, they will 
typically have overestimated coefficients.  
 
Appendix S2: The observed-expected complication rate and confidence intervals 
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We used the risk prediction model to produce expected IntraOp and PostOp CRs   for 
each hospital by summing the predicted risk for each surgery over each hospital. We 
then compared the expected with the observed CR, and if the confidence band for the 
CR ratio (defined as for the funnel plots: green (up to 80%), yellow (>80%-90%), 
orange (>90%-95%), and red (>95-98%)) contained 1, we denoted the hospital with 
the appropriate coloured warning. To incorporate the uncertainty involved in estimating 
the expected CR, as well as the choice of λ, the sampling distribution of the observed-
to-expected CR ratio was estimated by taking 1000 bootstrap samples of the full 
dataset. For each bootstrap sample the new observed-to-expected CR ratio was 
calculated for each hospital, based on a refitting of the lasso model with λ optimally 
selected. Confidence intervals for the ratio were based on the appropriate bias-
corrected centiles of the bootstrap-derived sampling distribution. 
 
 
 
References: 
1. Tibshirani R. Regression shrinkage and selection via the Lasso. J Roy Stat 
Soc B Met 1996;58(1):267-88  
2. Royston P, Sauerbrei W. Multivariable Model-Building: A Pragmatic 
Approach to Regression Analysis Based on Fractional Polynomials for 
Modelling Continuous Variables. Wiley: Chichester, UK 2008  
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Figure 1: Comparison of intraoperative (a and b) and patient reported postoperative (c and d) complication rates. Left hand panels plot observed rates over colour-coded funnel plots where the yellow band/line 
represents a 80-90% control limit, the orange band/line a 90-95% control limit, and the red band/line a 95-98% control limit around overall rate. Right hand panels plot ratio of observed to expected rate against the 
null value of one, with colour-coded confidence intervals representing the same interval range as for the funnel plots. All plotted rates are also colour-coded, reflecting the position of the observed rate (left panels) or 
null value (right panels) within the appropriate coloured band.  
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Table 1: Risk prediction model for intra-operative complications -  full sample of hospital reported outcomes n=2948 
Variables 
Lasso Maximum Likelihood 
Shrinkage 
OR p-value* L95% CI* U95% CI* OR p-value L95% CI U95% CI 
Age at surgery 1.000 0.977 0.985 1.015 1.001 0.859 0.986 1.017 -84.0% 
BMI removed       1.003 0.867 0.974 1.032 -100.0% 
Previous abdominal surgery 1.426 0.058 0.988 2.057 1.459 0.045 1.008 2.111 -6.0% 
Low albumin 3.916 0.118 0.709 21.645 4.461 0.080 0.836 23.799 -8.7% 
Coagulation-thrombosis 1.052 0.910 0.436 2.540 1.148 0.755 0.483 2.729 -63.1% 
Diabetes 1.804 0.032 1.052 3.095 1.923 0.018 1.118 3.306 -9.7% 
Cardiac 1.462 0.205 0.812 2.632 1.572 0.128 0.878 2.814 -15.9% 
Respiratory 0.676 0.266 0.339 1.348 0.573 0.133 0.277 1.185 -29.8% 
Gastrointestinal 1.065 0.893 0.425 2.668 1.188 0.703 0.490 2.879 -63.5% 
Genitourinary 0.699 0.679 0.129 3.805 0.486 0.483 0.065 3.651 -50.4% 
Musculoskeletal removed       1.091 0.791 0.574 2.071 -100.0% 
Neurology-psychiatric removed       1.028 0.940 0.501 2.109 -100.0% 
Vascular 0.849 0.775 0.276 2.607 0.675 0.527 0.199 2.286 -58.3% 
Auto-immune 1.968 0.253 0.617 6.282 2.132 0.191 0.685 6.642 -10.6% 
Metabolic-endocrine 0.412 0.027 0.187 0.906 0.329 0.010 0.141 0.768 -20.3% 
Integumentary-dermatology removed       0.964 0.965 0.191 4.873 -100.0% 
Hypertension 1.239 0.325 0.808 1.899 1.279 0.263 0.831 1.969 -13.0% 
Smoking 0.978 0.969 0.323 2.961 0.828 0.760 0.246 2.788 -88.2% 
Other neoplasms 1.506 0.246 0.755 3.004 1.590 0.182 0.805 3.140 -11.8% 
Laparoscopic approach 1.021 0.935 0.618 1.689 1.240 0.403 0.749 2.051 -90.2% 
ASA                   
ASA grade 1 1       1         
ASA grade 2 1.103 0.699 0.670 1.816 1.250 0.401 0.742 2.106 -56.0% 
ASA grade 3+ 1.039 0.908 0.539 2.003 1.183 0.628 0.599 2.336 -77.0% 
Surgeon grade                   
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Consultant 1       1         
Sub-specialty trainee 0.716 0.604 0.202 2.535 0.614 0.460 0.168 2.243 -31.6% 
General Obstetrics & Gynaecology Trainee 1.286 0.673 0.399 4.144 1.243 0.720 0.378 4.083 15.8% 
Surgical complexity                   
Complexity score 1&2 1       1         
Complexity score 3&4 1.097 0.692 0.695 1.731 1.263 0.325 0.794 2.009 -60.4% 
Complexity score 5&6 1.905 0.016 1.130 3.212 2.208 0.003 1.298 3.756 -18.6% 
Complexity score 7&8 2.666 0.012 1.242 5.725 3.080 0.004 1.434 6.612 -12.8% 
Complexity score >8 4.005 0.003 1.626 9.865 4.561 0.001 1.850 11.242 -8.6% 
Final diagnosis                   
Ovarian  1       1         
Uterine 0.600 0.050 0.360 1.001 0.504 0.011 0.296 0.856 -25.5% 
Cervical  0.834 0.636 0.393 1.769 0.696 0.361 0.320 1.514 -49.9% 
Vulval 0.289 0.049 0.084 0.993 0.195 0.026 0.046 0.826 -24.1% 
Benign 0.567 0.041 0.329 0.976 0.508 0.017 0.291 0.887 -16.2% 
Constant 0.033 0.000 0.007 0.146 0.025 0.000 0.004 0.145 -32.8% 
* for approximate guidance only          
 
  
4 
 
Table 2: Summary of intraoperative and postoperative complications by centre 
a) Intraoperative complications summary -  full sample of hospital reported outcomes n=2948 
Hospital 
Number of 
surgeries 
Number IO1 
complications 
Observed IO 
CR2 
Expected 
number IO 
complications 
Expected IO 
CR 
O/E3 IO CR 
ratio 
Lower 95% CI4 
for O/E ratio 
Upper 95% CI 
for O/E ratio 
A 230 13 5.7% 11.7 5.1% 1.116 0.689 1.698 
B 493 17 3.4% 25.6 5.2% 0.664 0.390 0.977 
C 251 10 4.0% 11.6 4.6% 0.865 0.389 1.307 
D 825 44 5.3% 41.7 5.1% 1.055 0.826 1.333 
E 181 14 7.7% 8.0 4.4% 1.761 1.072 2.554 
F 201 4 2.0% 10.2 5.1% 0.393 0.102 0.804 
G 91 6 6.6% 3.6 3.9% 1.681 0.481 3.189 
H 242 11 4.5% 10.6 4.4% 1.035 0.598 1.659 
I 284 8 2.8% 12.6 4.4% 0.635 0.298 1.081 
J 150 12 8.0% 8.1 5.4% 1.479 0.838 2.313 
b) Postoperative complications summary – sample restricted to hospital and patient reported outcomes  n=1462 
Hospital 
Number of 
surgeries 
Number PO5 
complications 
Observed PO 
CR 
Expected 
number PO 
complications 
Expected PO 
CR 
O/E PO CR 
ratio 
Lower 95% CI 
for O/E ratio 
Upper 95% CI 
for O/E ratio 
A 82 20 24.4% 20.9 25.4% 0.958 0.616 1.325 
B 285 76 26.7% 69.7 24.4% 1.091 0.942 1.296 
C 36 12 33.3% 10.3 28.5% 1.171 0.688 1.723 
D 394 110 27.9% 108.2 27.5% 1.017 0.902 1.128 
E 129 30 23.3% 33.0 25.5% 0.910 0.638 1.157 
F 113 29 25.7% 28.2 24.9% 1.029 0.769 1.370 
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G 45 7 15.6% 11.1 24.8% 0.628 0.265 1.098 
H 162 44 27.2% 40.5 25.0% 1.086 0.881 1.355 
I 158 27 17.1% 31.8 20.1% 0.850 0.562 1.099 
J 58 21 36.2% 15.4 26.6% 1.361 0.917 1.828 
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Table 3: Risk prediction model for Postoperative complications – sample restricted to hospital and patient reported outcomes n=1462 
Variables 
Lasso Maximum Likelihood 
Shrinkage 
OR p-value* L95% CI* U95% CI* OR p-value L95% CI U95% CI 
Age at surgery 0.997 0.552 0.986 1.008 0.991 0.160 0.979 1.003 -57.3% 
BMI 1.012 0.213 0.993 1.031 1.020 0.059 0.999 1.041 -38.6% 
Previous abdominal surgery 1.008 0.954 0.774 1.313 1.096 0.501 0.838 1.434 -90.4% 
Coagulation-thrombosis 1.510 0.202 0.802 2.842 2.130 0.022 1.115 4.072 -45.1% 
Diabetes 1.355 0.145 0.901 2.038 1.565 0.038 1.024 2.392 -31.3% 
Cardiac removed       1.036 0.878 0.660 1.627 -100.0% 
Respiratory removed       1.146 0.536 0.744 1.763 -100.0% 
Gastrointestinal 0.916 0.798 0.467 1.796 0.673 0.291 0.322 1.405 -77.4% 
Genitourinary removed       1.371 0.490 0.560 3.354 -100.0% 
Musculoskeletal 1.254 0.265 0.842 1.868 1.555 0.033 1.037 2.333 -50.3% 
Neurology-psychiatric 0.908 0.722 0.533 1.546 0.693 0.217 0.387 1.241 -69.0% 
Vascular 0.926 0.847 0.423 2.024 0.692 0.412 0.287 1.669 -78.6% 
Auto-immune removed       0.531 0.366 0.134 2.098 -100.0% 
Metabolic-endocrine removed       1.120 0.586 0.744 1.688 -100.0% 
Integumentary-dermatology removed       0.981 0.977 0.262 3.672 -100.0% 
Hypertension removed       1.129 0.431 0.834 1.530 -100.0% 
Smoking removed       1.341 0.467 0.609 2.955 -100.0% 
Other neoplasms removed       1.167 0.577 0.678 2.009 -100.0% 
Laparoscopic approach 0.739 0.084 0.525 1.042 0.649 0.020 0.451 0.935 -28.7% 
ASA                   
ASA grade 1 1                 
ASA grade 2 removed       0.942 0.745 0.659 1.348 -100.0% 
ASA grade 3+ removed       0.812 0.407 0.497 1.328 -100.0% 
Surgeon grade                   
Consultant 1                 
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Sub-specialty trainee removed       0.864 0.658 0.453 1.648 -100.0% 
General Obstetrics & Gynaecology Trainee removed       0.873 0.656 0.480 1.588 -100.0% 
Surgical complexity                   
Complexity score 1&2 1                 
Complexity score 3&4 1.112 0.437 0.851 1.454 1.322 0.078 0.969 1.804 -61.8% 
Complexity score 5&6 removed       1.054 0.819 0.670 1.659 -100.0% 
Complexity score 7&8 1.056 0.881 0.516 2.163 1.480 0.313 0.691 3.169 -83.3% 
Complexity score >8 1.004 0.970 0.828 1.217 1.748 0.322 0.579 5.279 -90.6% 
Final diagnosis                   
Ovarian  1                 
Uterine 0.982 0.911 0.719 1.343 0.951 0.790 0.658 1.376 -82.5% 
Cervical  1.606 0.094 0.923 2.794 2.099 0.016 1.148 3.836 -33.4% 
Vulval 1.779 0.030 1.056 2.999 2.274 0.003 1.311 3.943 -27.7% 
Benign removed       1.058 0.775 0.720 1.554 -100.0% 
Duration of surgery (hrs) 1.086 0.003 1.028 1.146 1.081 0.018 1.014 1.152 -6.5% 
Estimated blood loss                   
<500ml 1                 
500ml-1000ml 1.267 0.208 0.876 1.833 1.405 0.077 0.963 2.048 -32.1% 
1000ml-2500ml 1.052 0.860 0.600 1.843 1.249 0.442 0.709 2.202 -76.4% 
>2500ml 0.997 0.962 0.867 1.146 0.506 0.417 0.098 2.623 -86.6% 
constant 0.167 0.000 0.066 0.422 0.179 0.003 0.057 0.564 -25.5% 
* for approximate guidance only.    Low albumin not included in the model as only one instance of it amongst 1462 surgeries 
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Figure S1: Comparison of observed postoperative complication rates against colour-coded funnel plots. Bright colour-coding and circle markers represent patient-reported 
statistics and faded colour-coding and square markers represent hospital reported statistics only.  
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Table S1: Intra-operative complications  
Anaesthetic complications    
Cardiac e.g. Cardiac arrythmias, Intra-operative cardic arrest 
Respiratory e.g. Aspiration, pneumothorax, pulmonary oedema 
Allergic reactions Allergic reactions including anaphylaxis 
Injury to viscera   
Uterine perforation Perforation of uterus during instrumentation 
Vascular injury 
Injury to major blood vessel e.g. superior and inferior mesenteric, renal, aorta, 
Inferior vena cava, iliacs, femorals, 
GI tract injury – Stomach Accidental injury involving complete penetration Into the lumen: Stomach 
GI tract injury – Small bowel Accidental injury involving complete penetration Into the lumen:Small bowel 
GI tract injury – Large bowel Accidental injury involving complete penetration Into the lumen: Large bowel 
Bladder injury Accidental bladder injury (full thickness) 
Ureteric injury Ligation / Transection / Diathermy burn 
Intra-operative Haemorrhage Estimated blood loss >2.5l 
Other intra-operative complications 
(give details) 
 Other intraoperative complications not included in the list 
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Table S2: Post-operative complications 
Abscess/Haematoma Pelvic or abdominal abscess / haematoma 
Anastomotic leak 
Anastomotic leak: Small bowel 
Anastomotic leak: Large bowel 
Ileus Post op Ileus requiring NG tube / Total parental nutrition 
Bowel obstruction Bowel Obstruction – small bowel 
  Bowel Obstruction – large bowel 
Bowel perforation Small / large bowel 
Bowel - other Constipation / Diarrhoea / faecal incontinence/urgency 
Bladder  
Urinary retention requiring catheterisation 
Urinary obstruction 
Incontinence- stress / urge  
Cardiac Atrial fibrillation, Myocardial infarction, Cardiac failure & other cardiac 
problems 
DVT Confirmed DVT on imaging / Doppler 
PE Confirmed PE on imaging 
Fistula 
Enterocutaneous 
Enterovaginal 
Vesicovaginal 
Ureterovaginal 
Other types of fistula 
Hernia Hernia as a result of surgery  
Infection 
Pyrexia (>38.5°C on 2 separate occasions) after 48 hours post op requiring 
antibiotics or infection confirmed by culture 
MRSA/ C. difficile 
Lymphocyst/Lymphoedema 
Lymphoedema  
Lymphocyst 
Neurological Neuropathic pain/ paraesthesia / nerve palsy 
11 
 
Psychiatric unexpected psychiatric problems postoperatively e.g. Delirium, Psychosis, 
Depression and other  
Primary haemorrhage Haemorrhage within 24 hours of surgery  
Secondary haemorrhage Haemorrhage after 24hours  of surgery  
Respiratory Pulmonary oedema, Pneumothorax, Atelectasis, Pleural effusion and other 
respiratory problems excluding pneumonia (to be included in infections) 
Ureteric Obstruction Ureteric obstruction postoperative  
Wound breakdown 
Wound breakdown: Superficial - skin & subcutaneous tissue 
Wound breakdown: Deep - involving fascia / muscle 
Burst abdomen requiring repair under anaesthesia 
Other Other postoperative complications not included in the list  
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Table S3: Full dataset used for intra-operative complication analysis and hospital reported post operative complications n=2948 
 Hospital 
Overall 
chi2 df pvalue  A B C D E F G H I J 
 N % N % N % N % N % N % N % N % N % N % N % 
Intraop complications 13 5.7 17 3.5 10 4.0 44 5.3 14 7.7 4 2.0 6 6.6 11 4.6 8 2.8 12 8.0 139 4.7 16.8 9 0.0517 
Postop complications (hospital reported) 40 17.4 56 11.4 30 12.0 159 19.3 18 9.9 26 12.9 16 17.6 25 10.3 32 11.3 22 14.7 424 14.4 32.0 9 0.0002 
Previous abdominal surgery 83 36.1 168 34.1 64 25.5 306 37.1 42 23.2 84 41.8 33 36.3 109 45.0 117 41.2 19 12.7 1,025 34.8 75.6 9 0.0000 
Low Albumin 0 0.0 5 1.0 0 0.0 1 0.1 0 0.0 0 0.0 1 1.1 3 1.2 0 0.0 1 0.7 11 0.4 17.7 9 0.0391 
Coagulation-thrombosis 9 3.9 16 3.3 12 4.8 24 2.9 8 4.4 9 4.5 6 6.6 17 7.0 9 3.2 6 4.0 116 3.9 11.9 9 0.2180 
Diabetes 21 9.1 52 10.6 30 12.0 94 11.4 12 6.6 15 7.5 5 5.5 30 12.4 18 6.3 21 14.0 298 10.1 17.2 9 0.0455 
Cardiac 17 7.4 55 11.2 32 12.8 75 9.1 21 11.6 23 11.4 7 7.7 29 12.0 27 9.5 22 14.7 308 10.5 10.5 9 0.3081 
Respiratory 21 9.1 58 11.8 21 8.4 74 9.0 14 7.7 20 10.0 5 5.5 37 15.3 21 7.4 16 10.7 287 9.7 16.6 9 0.0553 
Gastrointestinal 10 4.4 10 2.0 6 2.4 21 2.6 9 5.0 17 8.5 6 6.6 13 5.4 3 1.1 9 6.0 104 3.5 35.2 9 0.0001 
Genitourinary 2 0.9 5 1.0 2 0.8 7 0.9 6 3.3 5 2.5 0 0.0 14 5.8 8 2.8 3 2.0 52 1.8 37.2 9 0.0000 
Musculoskeletal 15 6.5 23 4.7 15 6.0 98 11.9 13 7.2 19 9.5 4 4.4 34 14.1 21 7.4 19 12.7 261 8.9 38.7 9 0.0000 
Neurology-psychiatric 18 7.8 37 7.5 12 4.8 65 7.9 8 4.4 15 7.5 7 7.7 17 7.0 22 7.8 7 4.7 208 7.1 6.7 9 0.6652 
Vascular 4 1.7 18 3.7 5 2.0 18 2.2 3 1.7 9 4.5 4 4.4 8 3.3 11 3.9 6 4.0 86 2.9 9.5 9 0.3916 
Infections 2 0.9 8 1.6 2 0.8 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 1 0.4 0 0.0 13 0.4 24.9 9 0.0031 
Auto-immune 4 1.7 8 1.6 2 0.8 6 0.7 3 1.7 5 2.5 0 0.0 2 0.8 5 1.8 3 2.0 38 1.3 8.5 9 0.4874 
Metabolic-endocrine 25 10.9 47 9.5 25 10.0 67 8.1 15 8.3 27 13.4 15 16.5 35 14.5 35 12.3 11 7.3 302 10.2 18.7 9 0.0282 
Integumentary-dermatology 4 1.7 2 0.4 3 1.2 6 0.7 1 0.6 3 1.5 0 0.0 8 3.3 3 1.1 0 0.0 30 1.0 19.7 9 0.0199 
Hypertension 61 26.5 186 37.7 72 28.7 257 31.2 66 36.5 78 38.8 19 20.9 110 45.5 71 25.0 53 35.3 973 33.0 48.4 9 0.0000 
Smoking 1 0.4 25 5.1 15 6.0 3 0.4 5 2.8 10 5.0 16 17.6 14 5.8 1 0.4 5 3.3 95 3.2 113.7 9 0.0000 
Other neoplasms 24 10.4 15 3.0 6 2.4 40 4.9 11 6.1 6 3.0 5 5.5 16 6.6 19 6.7 6 4.0 148 5.0 27.4 9 0.0012 
Surgeon grade                       302.4 18 0.0000 
General Obstetrics & Gynaecology Trainee 3 1.3 22 4.6 3 1.3 15 1.8 25 15.0 3 1.5 0 0.0 2 0.9 30 11.1 5 3.4 108 3.8    
Sub-specialty trainee 87 37.8 95 19.9 65 27.2 172 20.9 8 4.8 3 1.5 23 25.3 80 35.1 35 12.9 5 3.4 573 20.0    
Consultant 140 60.9 360 75.5 171 71.6 638 77.3 134 80.2 192 97.0 68 74.7 146 64.0 206 76.0 136 93.2 2,191 76.3    
Laparoscopic approach 109 47.4 40 8.1 44 17.5 208 25.2 8 4.4 11 5.5 26 28.6 62 25.6 152 53.5 21 14.0 681 23.1 373.2 9 0.0000 
ASA Grade                       145.5 27 0.0000 
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ASA grade 1 44 19.2 142 28.8 107 43.3 194 23.5 32 17.7 58 28.9 23 25.3 19 7.9 97 34.2 38 25.3 754 25.6    
ASA grade 2 149 65.1 262 53.1 115 46.6 438 53.1 93 51.4 101 50.3 56 61.5 156 65.0 138 48.6 79 52.7 1,587 54.0    
ASA grade 3+ 36 15.7 89 18.1 25 10.1 193 23.4 56 30.9 42 20.9 12 13.2 65 27.1 48 16.9 33 22.0 599 20.4    
Surgical complexity                       228.9 36 0.0000 
Complexity score 1&2 97 42.2 149 30.2 160 63.8 395 47.9 118 65.2 72 35.8 48 52.8 124 51.2 181 63.7 54 36.0 1,398 47.4    
Complexity score 3&4 79 34.4 199 40.4 62 24.7 276 33.5 38 21.0 88 43.8 39 42.9 79 32.6 70 24.7 52 34.7 982 33.3    
Complexity score 5&6 41 17.8 111 22.5 17 6.8 105 12.7 23 12.7 37 18.4 3 3.3 35 14.5 19 6.7 39 26.0 430 14.6    
Complexity score 7&8 9 3.9 24 4.9 5 2.0 34 4.1 2 1.1 4 2.0 1 1.1 3 1.2 6 2.1 5 3.3 93 3.2    
Complexity score >8 4 1.7 10 2.0 7 2.8 15 1.8 0 0.0 0 0.0 0 0.0 1 0.4 8 2.8 0 0.0 45 1.5    
Final diagnosis                       274.2 36 0.0000 
Ovarian 94 40.9 123 25.0 99 39.4 305 37.0 57 31.5 82 40.8 27 29.7 78 32.2 64 22.5 60 40.0 989 33.6    
Uterine 70 30.4 119 24.1 73 29.1 243 29.5 56 30.9 51 25.4 37 40.7 60 24.8 62 21.8 49 32.7 820 27.8    
Cervical 18 7.8 19 3.9 20 8.0 82 9.9 16 8.8 9 4.5 5 5.5 16 6.6 11 3.9 11 7.3 207 7.0    
Vulval 3 1.3 18 3.7 14 5.6 69 8.4 12 6.6 12 6.0 4 4.4 20 8.3 12 4.2 12 8.0 176 6.0    
Benign 45 19.6 214 43.4 45 17.9 126 15.3 40 22.1 47 23.4 18 19.8 68 28.1 135 47.5 18 12.0 756 25.6    
Estimated blood loss                       246.2 27 0.0000 
<500ml 155 67.4 400 82.0 196 78.7 709 87.4 93 51.4 161 80.9 69 75.8 198 81.8 261 93.2 93 62.0 2,335 79.9    
500ml-1000ml 50 21.7 49 10.0 33 13.3 62 7.6 69 38.1 23 11.6 12 13.2 31 12.8 11 3.9 38 25.3 378 12.9    
1000ml-2500ml 19 8.3 33 6.8 16 6.4 37 4.6 17 9.4 15 7.5 7 7.7 10 4.1 7 2.5 13 8.7 174 6.0    
>2500ml 6 2.6 6 1.2 4 1.6 3 0.4 2 1.1 0 0.0 3 3.3 3 1.2 1 0.4 6 4.0 34 1.2    
 mean sd mean sd mean sd mean sd mean sd mean sd mean sd mean sd mean sd mean sd mean sd F df* pvalue 
Age at surgery 58.6 13.8 59.5 15.4 58.4 15.7 60.6 15.0 63.2 12.1 63.1 13.6 57.2 12.0 63.3 16.0 59.6 14.4 64.1 14.0 60.6 14.8 5.2 9 0.0000 
BMI 27.6 6.7 28.8 6.9 28.2 8.3 29.1 7.2 30.0 6.8 28.5 6.1 29.6 8.4 29.2 6.7 28.9 6.4 28.4 6.7 28.8 7.0 2.1 9 0.0304 
Duration of surgery (hrs) 141 59.1 114 53.7 151 85.1 159 83.4 116 52.0 122 57.0 136 56.8 121 58.8 101 47.9 128 55.9 133.3 69.9 31.4 9 0.0000 
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Table S4: Subset used for post-operative complication analysis where both hospital and patient reported data was available n=1462 
 Hospital 
Overall 
chi2 df pvalue  A B C D E F G H I J 
 N % N % N % N % N % N % N % N % N % N % N % 
Intraop complications 3 3.7 10 3.5 2 5.6 22 5.6 10 7.8 3 2.7 3 6.7 8 4.9 5 3.2 2 3.5 68 4.7 7.1 9 0.6276 
Postop complications (hospital and patient 
reported) 
20 24.4 76 26.7 12 33.3 110 27.9 30 23.3 29 25.7 7 15.6 44 27.2 27 17.1 21 36.2 376 25.7 14.8 9 0.0960 
Previous abdominal surgery 23 28.1 99 34.7 13 36.1 141 35.8 30 23.3 42 37.2 14 31.1 70 43.2 66 41.8 9 15.5 507 34.7 27.9 9 0.0010 
Low Albumin 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 1 0.6 0 0.0 0 0.0 1 0.1 8.0 9 0.5311 
Coagulation-thrombosis 3 3.7 9 3.2 2 5.6 12 3.1 7 5.4 3 2.7 3 6.7 11 6.8 5 3.2 1 1.7 56 3.8 8.3 9 0.4997 
Diabetes 7 8.5 28 9.8 5 13.9 43 10.9 6 4.7 7 6.2 3 6.7 22 13.6 13 8.2 11 19.0 145 9.9 15.8 9 0.0713 
Cardiac 5 6.1 36 12.6 10 27.8 29 7.4 15 11.6 12 10.6 3 6.7 17 10.5 18 11.4 8 13.8 153 10.5 20.4 9 0.0157 
Respiratory 7 8.5 40 14.0 3 8.3 26 6.6 9 7.0 11 9.7 2 4.4 22 13.6 10 6.3 4 6.9 134 9.2 19.0 9 0.0254 
Gastrointestinal 1 1.2 3 1.1 1 2.8 12 3.1 8 6.2 7 6.2 5 11.1 7 4.3 1 0.6 4 6.9 49 3.4 26.7 9 0.0016 
Genitourinary 2 2.4 2 0.7 0 0.0 2 0.5 4 3.1 1 0.9 0 0.0 11 6.8 6 3.8 0 0.0 28 1.9 34.3 9 0.0001 
Musculoskeletal 7 8.5 17 6.0 2 5.6 57 14.5 8 6.2 11 9.7 3 6.7 28 17.3 13 8.2 7 12.1 153 10.5 26.4 9 0.0017 
Neurology-psychiatric 5 6.1 14 4.9 1 2.8 22 5.6 5 3.9 7 6.2 2 4.4 12 7.4 16 10.1 4 6.9 88 6.0 8.0 9 0.5329 
Vascular 2 2.4 9 3.2 1 2.8 6 1.5 3 2.3 4 3.5 2 4.4 5 3.1 6 3.8 2 3.5 40 2.7 4.1 9 0.9046 
Infections 0 0.0 6 2.1 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 1 0.6 0 0.0 7 0.5 20.8 9 0.0136 
Auto-immune 1 1.2 3 1.1 1 2.8 4 1.0 3 2.3 2 1.8 0 0.0 1 0.6 2 1.3 0 0.0 17 1.2 4.4 9 0.8794 
Metabolic-endocrine 9 11.0 22 7.7 4 11.1 32 8.1 12 9.3 14 12.4 7 15.6 23 14.2 22 13.9 5 8.6 150 10.3 11.3 9 0.2567 
Integumentary-dermatology 2 2.4 0 0.0 1 2.8 1 0.3 1 0.8 1 0.9 0 0.0 6 3.7 1 0.6 0 0.0 13 0.9 23.7 9 0.0048 
Hypertension 25 30.5 113 39.7 12 33.3 127 32.2 47 36.4 47 41.6 12 26.7 74 45.7 51 32.3 17 29.3 525 35.9 17.2 9 0.0458 
Smoking 0 0.0 14 4.9 0 0.0 1 0.3 2 1.6 2 1.8 7 15.6 9 5.6 1 0.6 1 1.7 37 2.5 58.1 9 0.0000 
Other neoplasms 10 12.2 9 3.2 1 2.8 27 6.9 6 4.7 3 2.7 3 6.7 13 8.0 10 6.3 5 8.6 87 6.0 15.6 9 0.0768 
Surgeon grade                       201.5 18 0.0000 
General Obstetrics & Gynaecology Trainee 2 2.4 17 6.2 1 2.9 6 1.5 21 17.8 3 2.7 0 0.0 2 1.3 19 12.5 3 5.3 74 5.2    
Sub-specialty trainee 35 42.7 55 20.2 16 47.1 82 20.8 5 4.2 1 0.9 15 33.3 58 38.2 21 13.8 1 1.8 289 20.4    
Consultant 45 54.9 201 73.6 17 50.0 306 77.7 92 78.0 107 96.4 30 66.7 92 60.5 112 73.7 53 93.0 1,055 74.4    
Laparoscopic approach 37 45.1 21 7.4 4 11.1 99 25.1 8 6.2 6 5.3 15 33.3 43 26.5 91 57.6 9 15.5 333 22.8 220.3 9 0.0000 
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ASA Grade                       49.1 18 0.0001 
ASA grade 1 10 12.4 80 28.1 12 33.3 90 22.8 23 17.8 29 25.7 9 20.0 15 9.3 45 28.5 17 29.3 330 22.6    
ASA grade 2 58 71.6 155 54.4 21 58.3 230 58.4 70 54.3 64 56.6 32 71.1 106 65.8 82 51.9 29 50.0 847 58.0    
ASA grade 3+ 13 16.1 50 17.5 3 8.3 74 18.8 36 27.9 20 17.7 4 8.9 40 24.8 31 19.6 12 20.7 283 19.4    
Surgical complexity                       125.8 36 0.0000 
Complexity score 1&2 36 43.9 89 31.2 25 69.4 179 45.4 87 67.4 41 36.3 22 48.9 84 51.9 106 67.1 21 36.2 690 47.2    
Complexity score 3&4 30 36.6 115 40.4 9 25.0 143 36.3 27 20.9 46 40.7 20 44.4 53 32.7 38 24.1 23 39.7 504 34.5    
Complexity score 5&6 11 13.4 60 21.1 1 2.8 50 12.7 13 10.1 22 19.5 2 4.4 23 14.2 10 6.3 14 24.1 206 14.1    
Complexity score 7&8 3 3.7 16 5.6 0 0.0 15 3.8 2 1.6 4 3.5 1 2.2 2 1.2 1 0.6 0 0.0 44 3.0    
Complexity score >8 2 2.4 5 1.8 1 2.8 7 1.8 0 0.0 0 0.0 0 0.0 0 0.0 3 1.9 0 0.0 18 1.2    
Final diagnosis                       163.5 36 0.0000 
Ovarian 39 47.6 70 24.6 17 47.2 157 39.9 39 30.2 46 40.7 11 24.4 54 33.3 34 21.5 14 24.1 481 32.9    
Uterine 25 30.5 68 23.9 13 36.1 124 31.5 40 31.0 33 29.2 22 48.9 41 25.3 40 25.3 21 36.2 427 29.2    
Cervical 7 8.5 7 2.5 0 0.0 29 7.4 12 9.3 4 3.5 3 6.7 10 6.2 3 1.9 5 8.6 80 5.5    
Vulval 0 0.0 14 4.9 1 2.8 26 6.6 7 5.4 6 5.3 0 0.0 10 6.2 8 5.1 7 12.1 79 5.4    
Benign 11 13.4 126 44.2 5 13.9 58 14.7 31 24.0 24 21.2 9 20.0 47 29.0 73 46.2 11 19.0 395 27.0    
Estimated blood loss                          
<500ml 54 65.9 237 84.0 24 68.6 331 86.0 68 52.7 91 80.5 35 77.8 135 83.3 148 94.9 39 67.2 1,162 80.3 140.4 27 0.0000 
500ml-1000ml 20 24.4 25 8.9 8 22.9 35 9.1 46 35.7 14 12.4 5 11.1 21 13.0 4 2.6 17 29.3 195 13.5    
1000ml-2500ml 7 8.5 17 6.0 3 8.6 17 4.4 13 10.1 8 7.1 3 6.7 4 2.5 4 2.6 2 3.5 78 5.4    
>2500ml 1 1.2 3 1.1 0 0.0 2 0.5 2 1.6 0 0.0 2 4.4 2 1.2 0 0.0 0 0.0 12 0.8    
 mean sd mean sd mean sd mean sd mean sd mean sd mean sd mean sd mean sd mean sd mean sd F df* pvalue 
Age at surgery 59.6 12.2 60.5 14.4 62.1 12.8 62.8 12.8 63.1 11.7 63.8 12.3 59.1 11.8 64.5 14.8 62.0 12.9 65.4 13.3 62.4 13.3 2.4 9 0.0107 
BMI 27.8 7.8 28.8 6.7 31.1 8.8 28.5 6.8 29.7 6.6 28.3 5.5 30.2 10.0 29.2 6.9 29.1 6.3 28.6 6.3 28.9 6.9 1.2 9 0.2625 
Duration of surgery (hrs) 148.9 60.6 110.6 51.3 146.1 91.2 161.8 80.8 110.3 51.0 121.3 55.4 138.8 53.4 122.6 56.6 95.1 42.6 114.4 34.8 128.9 66.2 23.7 9 0.0000 
 
